Skip to content

Insider · CIK 0001889522

Ng Carey

Reports to the SEC for 1 company · LOS ANGELES, CA

Transactions

13

Companies

1

Filings

9

CIK

0001889522

Forms 4 and 5

Insider transactions

13 trades
DateCompanyValue
2026-05-22IMMXImmix Biopharma, Inc.A Award—
2026-05-22IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award—
2025-06-20IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award—
2024-08-16IMMXImmix Biopharma, Inc.P Purchase+$18.6K
2024-06-11IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award—
2024-05-15IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award—
2024-05-15IMMXImmix Biopharma, Inc. · Stock Option (Right to Buy)A Award—
2023-09-14IMMXImmix Biopharma, Inc.P Purchase+$25.8K
2023-08-11IMMXImmix Biopharma, Inc. · Stock OptionsA Award—
2022-07-14IMMXImmix Biopharma, Inc. · Stock OptionsA Award—
2021-12-20IMMXImmix Biopharma, Inc.C Conversion+$850K
2021-12-20IMMXImmix Biopharma, Inc.P Purchase+$125K
2021-12-20IMMXImmix Biopharma, Inc. · Convertible NoteC Conversion—

Recent filings

9

Companies

1

Address

C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200

LOS ANGELES, CA, 90064